Tag Archives: slowdown

FiercePharmaAsia—COVID-19 drug manufacturing; Roche’s China slowdown; Astellas’ Iota buy

Takeda and CSL Behring are scaling up manufacturing of their coronavirus hyperimmune drug, but its reliance on blood donations could be a bottleneck. Eli Lilly has signed on Fujifilm to help make its COVID-19 antibody therapy as part of a Bill & Melinda Gates Foundation initiative to bring drugs for low- and middle-income countries. Roche blames… Read More »

GBT chief blames COVID-19 for ‘clear’ slowdown in Oxbryta launch, but analysts are still impressed

Global Blood Therapeutics’ sickle cell disease medicine Oxbryta got off to a hot start after a November FDA approval. But early in its launch, execs now say they’re seeing a “clear headwind” from the COVID-19 pandemic. About 2,000 patients have been prescribed the new drug in the early months of the rollout. But lately, new patient… Read More »